Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK
BTK mutants lacking kinase activity recruit HCK to fuel B cell cancer growth.
BTK mutants lacking kinase activity recruit HCK to fuel B cell cancer growth.